ATE178800T1 - Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung - Google Patents

Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung

Info

Publication number: ATE178800T1
Authority: AT; Austria
Prior art keywords: glx; pharmaceutical; pentapeptide; pharmaceutically acceptable; composition
Prior art date: 1992-01-02

Application number

AT93902884T

Other languages

English (en)

Inventor

Vadim Tikhonovich Ivanov

Inessa Ivanovna Mikhalyova

Boris Victorovich Vaskovsky

Alexander Nickolaev Mikhaltsov

Vladimir Khatskelevi Khavinson

Vyacheslav Grigorievic Morozov

Original Assignee

Cytran Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-01-02

Filing date

1992-12-31

Publication date

1999-04-15

1992-12-31 Application filed by Cytran Ltd filed Critical Cytran Ltd

1999-04-15 Application granted granted Critical

1999-04-15 Publication of ATE178800T1 publication Critical patent/ATE178800T1/de

Links

208000001388 Opportunistic Infections Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

AT93902884T 1992-01-02 1992-12-31 Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung ATE178800T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US81620592A	1992-01-02	1992-01-02

Publications (1)

Publication Number	Publication Date
ATE178800T1 true ATE178800T1 (de)	1999-04-15

Family

ID=25219964

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93902884T ATE178800T1 (de)	1992-01-02	1992-12-31	Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung

Country Status (10)

Country	Link
EP (1)	EP0621789B1 (de)
JP (1)	JP3348851B2 (de)
AT (1)	ATE178800T1 (de)
AU (1)	AU3429393A (de)
CA (1)	CA2127275A1 (de)
DE (1)	DE69228945T2 (de)
DK (1)	DK0621789T3 (de)
ES (1)	ES2131105T3 (de)
GR (1)	GR3030600T3 (de)
WO (1)	WO1993012810A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5589458A (en) *	1992-11-13	1996-12-31	Thomas Jefferson University	Compounds that inhibit T cell proliferation and methods for using the same
RU2161974C1 (ru) *	2000-01-20	2001-01-20	Общество с ограниченной ответственностью "Клиника Института биорегуляции и геронтологии"	Лечебно-профилактическое средство для ухода за кожей (варианты)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4395404A (en) *	1982-05-14	1983-07-26	George Washington University	Synthetic thymosin β3 and β4 analogues
US4753927A (en) *	1983-08-12	1988-06-28	Immunetech Pharmaceuticals	Method of blocking immune complex binding to immunoglobulin Fc receptors
US5100663A (en) *	1984-08-24	1992-03-31	Imreg, Inc.	Tyr-Gly compositions useful in increasing immune response
US5093321A (en) *	1984-08-24	1992-03-03	Imreg, Inc.	Dialysates for treating aids and arc and for otherwise increasing immune response
US5081108A (en) *	1984-08-24	1992-01-14	Imreg, Inc.	Method of showing progression of AIDS in an ARC patient by treating with Tyr-Gly compositions
DK0613375T3 (da) *	1991-10-28	2004-07-12	Melmotte Inc	Farmaceutiske lysinholdige polypeptidpræparater og anvendelse deraf

1992
- 1992-12-31 CA CA002127275A patent/CA2127275A1/en not_active Abandoned
- 1992-12-31 EP EP93902884A patent/EP0621789B1/de not_active Expired - Lifetime
- 1992-12-31 DK DK93902884T patent/DK0621789T3/da active
- 1992-12-31 JP JP51197893A patent/JP3348851B2/ja not_active Expired - Fee Related
- 1992-12-31 AU AU34293/93A patent/AU3429393A/en not_active Abandoned
- 1992-12-31 ES ES93902884T patent/ES2131105T3/es not_active Expired - Lifetime
- 1992-12-31 WO PCT/US1992/011381 patent/WO1993012810A1/en not_active Ceased
- 1992-12-31 AT AT93902884T patent/ATE178800T1/de not_active IP Right Cessation
- 1992-12-31 DE DE69228945T patent/DE69228945T2/de not_active Expired - Fee Related
1999
- 1999-06-23 GR GR990401683T patent/GR3030600T3/el unknown

Also Published As

Publication number	Publication date
JP3348851B2 (ja)	2002-11-20
DE69228945D1 (de)	1999-05-20
DK0621789T3 (da)	1999-10-25
EP0621789B1 (de)	1999-04-14
WO1993012810A1 (en)	1993-07-08
EP0621789A4 (en)	1995-09-06
CA2127275A1 (en)	1993-07-08
DE69228945T2 (de)	1999-09-16
GR3030600T3 (en)	1999-10-29
JPH07506564A (ja)	1995-07-20
EP0621789A1 (de)	1994-11-02
ES2131105T3 (es)	1999-07-16
AU3429393A (en)	1993-07-28

Similar Documents

Publication	Publication Date	Title
DE69230500D1 (de)	2000-02-03	Pharmazeutische Dipeptid Zusammensetzungen und Verwendungsmethoden.
RU95107881A (ru)	1996-11-27	Фармацевтическая композиция для лечения аллергических заболеваний, способ антигистаминного лечения, применение композиции для получения лекарственного препарата
TW250435B (de)	1995-07-01
MX9200361A (es)	1992-07-01	Nuevo uso del antagonista de adenosina.
AU618443B2 (en)	1991-12-19	The use of the active substance azelastine in combatting psoriasis disorders and inflammatory disorders
RU92016463A (ru)	1995-09-10	Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
RU94002133A (ru)	1995-10-27	6-хлор-5-фтор-3-(2-теноил)-2-оксиндол-1-карбоксамид как аналгезирующее и противовоспалительное средство
TR199801184T2 (xx)	1998-09-21	Analjezik tesirli yeni bile�ikler.
DK0613375T3 (da)	2004-07-12	Farmaceutiske lysinholdige polypeptidpræparater og anvendelse deraf
DE69228945D1 (de)	1999-05-20	Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung
DE10299023I2 (de)	2010-05-06	Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
NO810480L (no)	1981-08-14	Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
DE68905076D1 (de)	1993-04-08	Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
CO5031290A1 (es)	2001-04-27	Formulacion lo
RU94032792A (ru)	1996-09-10	Применение 5нтiа - антагонистов для прекращения использования табака
SE8804640D0 (sv)	1988-12-23	Medicament comprising cyclolinopeptide a
ATE177638T1 (de)	1999-04-15	Topisch anzuwendendes arzneimittel enthaltend penciclovir
MX9303074A (es)	1994-01-31	Uso de la (e)-2-(p-fluorofenetil)-3-fluoroalilamina en el tratamiento de la enfermedad de elzheimer.
NO307126B1 (no)	2000-02-14	Anvendelse av biologisk aktive ureidoderivater for fremstilling av et medikament for bruk i behandlingen av lentivirusindusert sykdom
FI930097A7 (fi)	1993-01-11	Annostusmuoto lääkeaineen antamiseksi vuorokausiterapian toteuttamista varten
DE69429447D1 (de)	2002-01-24	Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
IT1243368B (it)	1994-06-10	Uso del bendazac e dei suoi sali farmaceuticamente accettabili
DE3777411D1 (de)	1992-04-16	Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.
ATE117725T1 (de)	1995-02-15	Antibiotikum ge1655-komplex und seine faktoren a,b und c.
GR77250B (de)	1984-09-11

Legal Events

Date	Code	Title	Description
1999-12-15	UEP	Publication of translation of european patent specification
2007-09-15	REN	Ceased due to non-payment of the annual fee